1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Clinical data for 8 patients with imaging changes after proton therapy
Patient Sex Diagnosis Location Age at Diagnosis (yr) Age at Proton Therapy (yr) 1 F EP Fourth ventricle 1.7 2.2 2 M EP Fourth ventricle 1.9 2.4 3 F CPC Left lateral ventricle 1.2 2.6 4 F PNET Left parietal lobe 2.7 3.2 5 F MB Fourth ventricle 1 1.4 6 F EP Fourth ventricle 3 3.5 7 F AT/RT Posterior fossa 0.6 1 8 M EP Fourth ventricle 2.2 2.6 Median 1.8 2.5 Mean 1.8 2.4
Note:—EP indicates ependymoma; MB, medulloblastoma.